Urinary tract infection and indirect hyperbilirubinemia in newborns

Chamdine Omar1, Shadi Hamza, Abou Merhi Bassem

  • 1Department of Pediatrics, Makassed General Hospital, Beirut, Lebanon.

Insights

Urinary tract infections (UTIs) can be present in newborns with jaundice, even without other symptoms. Early detection of UTIs in jaundiced infants is crucial for timely treatment.

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Clinical Pediatrics

Background:

  • Neonatal jaundice affects a significant proportion of newborns (60% term, 80% preterm).
  • Jaundice can be an indicator of serious underlying conditions, including urinary tract infections (UTIs).

Purpose of the Study:

  • To determine the incidence and prevalence of UTIs in newborns presenting with indirect hyperbilirubinemia.
  • To investigate the association between UTIs and prolonged jaundice in neonates.

Main Methods:

  • Retrospective evaluation of asymptomatic, jaundiced neonates for UTI.
  • Review of demographic, historical, blood study, radiological, and treatment data.

Main Results:

  • A UTI was identified in 32 out of 152 neonates (21.1%).
  • Klebsiella and Escherichia coli were the most common causative organisms.
  • Newborns with UTI required shorter phototherapy durations compared to those without UTI.

Conclusions:

  • Urinary tract infections can manifest as the primary condition in asymptomatic, jaundiced newborns.
  • Screening for UTIs in neonates with unexplained jaundice is recommended for early diagnosis and management.
Abstract

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...